The oral prescription medicine Onglyza (saxagliptin) is for type 2 diabetic adults, to control high blood sugar. The Onglyza diabetes drug, when used along with a healthy diet and exercise, is believed to lower A1C, first-in-the-morning and after meals blood sugar levels. It is intended to be taken along with another anti-diabetes medication such as metformin, a sulphonylurea, or a thiazolidinedione. Approved by the Food and Drug Administration (FDA), the Onglyza diabetes medication is a dipeptidyl peptidase-4 (DPP-4) inhibitor, which helps the pancreas release insulin, lowering blood sugar levels. High blood sugar can cause symptoms such as increased urination and blurry vision, and may eventually lead to vision problems and kidney disease.

Diabetes and Onglyza: A Safe Alternative to Januvia?

Some of the more common side effects for Onglyza include upper respiratory infection, headache, dizziness, fatigue, vomiting and urinary tract infection. One may also experience allergic reactions such …